Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
The site navigation utilizes arrow, enter, escape, and space bar key commands. Left and right arrows move across top level links and expand / close menus in sub levels. Up and Down arrows will open main level menus and toggle through sub tier links. Enter and space open menus and escape closes them as well. Tab will move on to the next part of the site rather than go through menu items.
The regulatory function is vital in making safe and effective healthcare products available worldwide. Individuals who ensure regulatory compliance and prepare submissions, as well as those whose main job function is clinical affairs or quality assurance are all considered regulatory professionals.
Share your knowledge and expertise with your regulatory peers by submitting an in-depth, evidence-based article focusing on key areas and emerging issues in the global regulatory landscape.
One of our most valuable contributions to the profession is the Regulatory Code of Ethics. The Code of Ethics provides regulatory professionals with core values that hold them to the highest standards of professional conduct.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Like all professions, regulatory is based on a shared set of competencies. The Regulatory Competency Framework describes the essential elements of what is required of regulatory professionals at four major career and professional levels.
RAPS Euro Convergence brings regulatory peers from the EU and worldwide together in one forum to gain insights and exchange ideas on the region's most pressing issues. Register today to attend 10-12 May 2021.
Registration is now open for RAPS Convergence 2021! Gather with the regulatory community 12-15 September for four days of learning, engagement, and excitement.
With contributions from more than 30 authors from seven countries, the new edition incorporates a global overview of the field and is designed to help you get the most out of your regulatory intelligence endeavors.
Regipedia is an interactive resource created to benefit RAPS members with 24/7 access to more than 2,300 regulatory terms.
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
The RAPS store will be under maintenance Saturday, 17 April between 5 AM and 12 PM EST. Store functionality may be unavailable at times during this window. We apologize for any inconvenience caused during this time.
Posted 09 August 2016 | By Zachary Brennan
Australia’s Therapeutic Goods Administration (TGA) on Tuesday announced upcoming changes to the way medicine labels on the island will look and be laid out in order to make more pertinent information about medicines easier to find.
The changes, which will be implemented over four years beginning 31 August 2016, will be made available in Australia’s Federal Register of Legislation from 17 August 2016, along with guidance on how to apply the new labeling orders.
The four-year transition period will allow drug sponsors time to adapt to the new requirements, and from 1 September 2020 all new medicine labels will need to meet the new requirements, TGA says.
Since labeling requirements for Australian drugs have not been amended since 2014, the update will further align the labels with international best practice, TGA says.
The main changes include:
“Prescription medicines will also have a designated space for a dispensing label,” TGA explains. “These labels are applied by the pharmacist and include important information like your name and dosage instructions. The defined space for a dispensing label space will help ensure that other information included on a carton or bottle is not covered.” In terms of the regulations, the label requirements have been split into two new labeling orders:
TGA says the split was applied to better consider the different risk levels for prescription and non-prescription medicines and also to improve overall readability.
During the four-year transition period, pharmaceutical sponsors can choose to comply with the old labeling requirements under TGO 69 or the new labeling requirements under TGO 91/92 (whichever applies).
“Labels must fully comply with all requirements of either the old or the relevant new Order. A label cannot selectively comply with parts of multiple Orders,” TGA says.
After the transition period, all medicines must comply with either TGO 91 or TGO 92.
Australia's medicine labels are becoming clearer
Tags: Australia drug labels, drug label, drug labeling changes, dispensing label
Regulatory Focus newsletters
All the biggest regulatory news and happenings.